Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.9 USD | -3.06% | +1.78% | 0.00% |
Business Summary
Number of employees: 61
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bladder-sparing Therapeutic
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +6.81% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +6.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arthur Kuan
CEO | Chief Executive Officer | 34 | 17-11-29 |
Ambaw Bellete
PSD | President | 54 | 23-06-30 |
Vijay Kasturi
CTO | Chief Tech/Sci/R&D Officer | 57 | 23-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Graf
BRD | Director/Board Member | 52 | Nov. 19 |
Leonard Post
BRD | Director/Board Member | 72 | 18-10-21 |
Victor Tong
BRD | Director/Board Member | 41 | 23-06-30 |
James Mulé
BRD | Director/Board Member | 72 | 18-10-21 |
Arthur Kuan
CEO | Chief Executive Officer | 34 | 17-11-29 |
Hong Fang Song
BRD | Director/Board Member | 59 | 15-10-31 |
Brian Liu
BRD | Director/Board Member | 36 | 22-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,640,150 | 61,943,223 ( 92.95 %) | 0 | 92.95 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.4B | |
+55.55% | 59.34B | |
+43.17% | 40.24B | |
-4.71% | 39.88B | |
-5.56% | 28.55B | |
+13.76% | 27.26B | |
-22.00% | 19.23B | |
+31.50% | 12.61B | |
+2.16% | 12.49B | |
+25.70% | 12.28B |
- Stock Market
- Equities
- CGON Stock
- Company CG Oncology, Inc.